Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | calpain-like protein, putative | 0.0021 | 0.0939 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0057 | 0.6473 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.5158 | 0.5158 |
Echinococcus multilocularis | calpain family protein 1, d | 0.004 | 0.3912 | 0.5373 |
Entamoeba histolytica | calpain large subunit domain III containing protein | 0.0014 | 0 | 0.5 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Echinococcus granulosus | calpain A | 0.0057 | 0.6473 | 1 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Brugia malayi | calpain 7 | 0.0021 | 0.0939 | 0.0939 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Echinococcus multilocularis | calpain A | 0.0057 | 0.6473 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.004 | 0.3912 | 0.3912 |
Trypanosoma brucei | calpain-like protein, putative | 0.0021 | 0.0939 | 1 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0057 | 0.6473 | 1 |
Loa Loa (eye worm) | calpain | 0.0021 | 0.0939 | 0.0939 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0057 | 0.6473 | 1 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0057 | 0.6473 | 1 |
Plasmodium vivax | calpain, putative | 0.0021 | 0.0939 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0055 | 0.6098 | 0.9322 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0055 | 0.6098 | 0.6098 |
Loa Loa (eye worm) | POT family protein | 0.008 | 1 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.0021 | 0.0939 | 1 |
Leishmania major | calpain, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0014 | 0 | 0.5 |
Brugia malayi | calpain family protein 1 | 0.0055 | 0.6098 | 0.6098 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.3912 | 0.3912 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.6098 | 0.6098 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma brucei | antigen, putative | 0.0021 | 0.0939 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.0021 | 0.0939 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.2973 | 0.2973 |
Onchocerca volvulus | 0.0034 | 0.2973 | 0.5 | |
Brugia malayi | calpain family protein 1 | 0.0055 | 0.6098 | 0.6098 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.0021 | 0.0939 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 74.5 uM | Inhibition of Clostridium botulinum recombinant Bont/A light chain expressed in Escherichia coli BL21 GOLD | ChEMBL. | 19329331 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.